Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts

US Patent 6900212 · Granted May 31, 2005

Estimated economic value: $131,524,000

Assignee

Inventors

View full patent text on Google Patents →